Publications & Works

Publication Network
Articles 27
All (27)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (13)
ESCI (6)
Scopus (15)
TRDizin (14)
Other Publications (2)

1. CD34+ cell dose as a determinant of engraftment kinetics after autologous stem cell transplantation in lymphoma

SARICI A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.
Journal of Current Hematology & Oncology Research , vol.4, 2026 (TRDizin)

2. The Effect of Nutritional Support on Malnutrition and Muscle Loss in Hematological Cancer Patients: A Retrospective Single-center Study

SARICI A., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., Arslan S., et al.
Acta Haematologica Oncologica Turcica , 2026 (TRDizin)

3. Effect of Interleukin 6 Levels on Allogeneic Stem Cell Transplantation

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
Journal of Applied Hematology , vol.17, pp.161-165, 2026 (Scopus)

4. Ferric Derisomaltose Compared to Iron Sucrose in Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

TANRIVERDİ L. H., SARICI A., Aksan F., Hernandez A. V.
Journal of Clinical Medicine , vol.15, no.5, 2026 (SCI-Expanded, Scopus)

5. A novel preemptive approach to plerixafor use in mobilization failure

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
MARMARA MEDICAL JOURNAL , vol.39, no.1, pp.24-31, 2026 (ESCI, Scopus, TRDizin)

6. The Impact of Ferritin Levels on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: Real-Life Data

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
Selçuk Tıp Dergisi , vol.42, no.2, pp.168-174, 2026 (TRDizin)

7. Venetoclax-Ibrutinib Combinations as First-Line Therapy in Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials with GRADE Approach

TANRIVERDİ L. H., SARICI A.
Archives of Basic and Clinical Research , vol.8, no.1, pp.7-19, 2026 (TRDizin)

8. A RARE DIAGNOSIS IN ADULTS: HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA

ARSLAN S., BERBER İ., KUKU İ., KAYA E., ERKURT M. A., SARICI A., et al.
Hematology, Transfusion and Cell Therapy , vol.47, pp.9-1, 2025 (ESCI, Scopus)

9. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?

ERKURT M. A., Yilmaz S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

10. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., Yilmaz S., Demircioglu S., BERBER İ., Basturk A., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

11. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Karakus A., Hatipoglu U., Katircilar Y., ERKURT M. A., Yilmaz S., Cagliyan G. A., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

12. EFFICACY OF ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS WITH ANEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

TANRIVERDİ L. H., UYSAL A., AKYAY A., ÖNCÜL Y., SARICI A.
Hematology, Transfusion and Cell Therapy , vol.47, pp.5-6, 2025 (ESCI, Scopus)

13. Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tanriverdi L. H., SARICI A.
Turkish Journal of Hematology , vol.42, no.2, pp.119-135, 2025 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

14. Efficacy of Ruxolitinib in the management of chronic GVHD

Giden A. O., ERKURT M. A., Hindilerden I. Y., Hidayet E., BERBER İ., Tiryaki T. O., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

15. Effectiveness of ibrutinib in the management of chronic GVHD

ERKURT M. A., SARICI A., Sahin A., BERBER İ., Korkmaz G., KUKU İ., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

16. Safety Profile of Roxadustat in Anemic Patients: A Meta-Analysis of 21 RCTs

TANRIVERDİ L. H., SARICI A., ERKURT M. A., BERKTAŞ H. B.
Medeniyet medical journal , vol.40, pp.250-261, 2025 (ESCI, Scopus, TRDizin)

17. Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
ACTA HAEMATOLOGICA POLONICA , vol.55, 2024 (Scopus)

18. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

Çelik S., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.
Journal of Current Hematology & Oncology Research , vol.2, 2024 (TRDizin)

19. Efficacy and safety of molidustat for the anemia of chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials

TANRIVERDİ L. H., Tay M., SARICI A.
Annals of Medical Research , vol.31, no.2, pp.177-184, 2024 (TRDizin) Creative Commons License

20. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients

BİÇİM S., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KAYA A., et al.
IRAQI JOURNAL OF HEMATOLOGY , vol.13, 2024 (ESCI, Scopus) Creative Commons License

21. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Thalassemia: A Single-Center Experience and Literature Review

UYSAL A., ERKURT M. A., SARICI A., KUKU İ., BİÇİM S., HİDAYET E., et al.
Fırat Tıp Dergisi , vol.28, no.1, pp.46-50, 2023 (TRDizin)

22. A case of malignant melanoma presented with lombar vertebra fracture

SARICI A., KUKU İ., BERBER İ., ERKURT M. A., ER ULUBABA H., BİÇİM S., et al.
Journal of Current Hematology & Oncology Research , vol.1, 2023 (TRDizin) Creative Commons License

23. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

KAYA A., BERBER İ., KUKU İ., ÇELİK S., KAYA E., BİÇİM S., et al.
Journal of Current Hematology & Oncology Research , vol.1, 2023 (TRDizin) Creative Commons License

24. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
MARMARA MEDICAL JOURNAL , vol.36, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

25. Convalescent plasma therapy in COVID-19

UYSAL A., ERKURT M. A., KUKU İ., SARICI A., BİÇİM S., KAYA E., et al.
Medicine Science , vol.11, no.2, pp.920-923, 2022 (TRDizin)

26. Pas III Added Donor Platelet Suspensions on Platelet Count Ph and Allergic Transfusion Reactions

Özgül M., KUKU İ., ERKURT M. A., SARICI A., BİÇİM S., BERBER İ., et al.
International Journal of Research and Reports in Hematology , vol.4, no.2, 2021 (Peer-Reviewed Journal)

27. Repeat Ultrasonographic Examinations Reveal Accessory Spleen in a Case with Relapse ITP

SARICI A., SLOCUM A., ULUBABA H. E., KANDEMİR M. H., ERKURT M. A., KAYA E., et al.
International Journal of Blood Research and Disorders , vol.6, no.1, pp.1-3, 2019 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 30

1. Otolog Nakil Yapılan Yaşlı Multipl Myelom Hastalarında CONUT Skorunun Prognoza Etkisi

AVCIL A., KAYA E., ERKURT M. A., KUKU İ., BERBER İ., SARICI A.
18. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 16 April 2026, (Full Text)

2. Asciminib in chronic myeloid leukemia: Superior efficacy and favorable safety outcomes from a systematic review and meta-analysis

SARICI A., TANRIVERDİ L. H., Hernandez A. V., ALTUNTAŞ F., Saglio G.
67th Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 06 December 2025, vol.146, pp.7298, (Summary Text)

3. Multipl Miyelom Hastalarında Transplantasyon Öncesi Conut Skorunun Transplantasyon Sonrası Engraftman Kinetiği ve Genel Sağ kalım Üzerindeki Etkisi

ARSLAN S., SARICI A., KAYA E., KUKU İ., ERKURT M. A., BERBER İ.
51. Ulusal Hematoloji Kongresi’, Antalya, Turkey, 28 October - 01 November 2025, pp.249-250, (Summary Text)

4. TCL-367: A Case of T-PLL Refractory to Multiple Treatments

Arslan S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BOZDAĞ Z., et al.
Society of Hematologic Oncology Thirteenth Annual Meeting, Houston, United States Of America, 3 - 06 September 2025, vol.25, (Summary Text)

5. Hope or Hazard? The Safety Profile of Roxadustat in Patients With Anemia

SARICI A., BERKTAŞ H. B., ERKURT M. A., TANRIVERDİ L. H.
Annual meeting of the Society of Hematologic Oncology (SOHO 2024), 4 - 07 September 2024, vol.25, pp.653, (Summary Text)

6. EFFICACY OF ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS WITH ANEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

TANRIVERDİ L. H., UYSAL A., AKYAY A., ÖNCÜL Y., SARICI A.
EHOC 2025, İstanbul, Turkey, 18 - 20 May 2025, (Summary Text)

7. PHARMACOVIGILANCE OF DRUG-INDUCED LEUKEMIA: A DESCRIPTIVE STUDY OF FDA ADVERSE EVENT REPORTING SYSTEM FROM 1969-2024

SARICI A., TANRIVERDİ L. H.
Hematology Specialist Association 18. National Congress, Antalya, Turkey, 21 - 24 November 2024, vol.46, (Summary Text)

8. CLL-247 Venetoclax Plus Ibrutinib As First-line Treatment in Patients With Chronic Lymphocytic Leukemia: Meta-Analysis of Randomised Controlled Trials

TANRIVERDİ L. H., SARICI A.
Society of Hematologic Oncology 2024 Annual Meeting, Texas, United States Of America, 4 - 07 September 2024, vol.24, pp.349, (Summary Text)

9. FERRİK DERİSOMALTOZ'UN DEMİR SÜKROZ İLE KARŞILAŞTIRILDIĞINDA DEMİR EKSİKLİĞİ ANEMİSİ OLAN HASTALARDA ETKİLİLİĞİ VE GÜVENİLİRLİĞİ: RANDOMİZE KONTROLLÜ ÇALIŞMALARIN SİSTEMATİK DERLEMESİ VE META-ANALİZİ

Tanriverdi L. H., Sarici A., Aksan F., Hernandez A. V.
27. Ulusal, 2. Uluslararası Farmakoloji Kongresi, Antalya, Turkey, 23 - 26 November 2023, pp.249-250, (Summary Text)

10. DEMİR EKSİKLİĞİ ANEMİSİNDE FERRİK KARBOKSİMALTOZ VE DEMİR SÜKROZUN ETKİLİLİĞİ: RANDOMİZE KONTROLLÜ ÇALIŞMALARIN SİSTEMATİK DERLEMESİ VE META-ANALİZİ

Tanriverdi L. H., Sarici A.
27. Ulusal, 2. Uluslararası Farmakoloji Kongresi, Antalya, Turkey, 23 - 26 November 2023, pp.257-258, (Summary Text)

11. MPN-139 Is Ferric Carboxymaltose a Safer Option Compared to Iron Sucrose?

Sarıcı A., Tanrıverdi L. H.
Society of Hematologic Oncology 2023 Annual Meeting, Texas, United States Of America, 6 - 09 September 2023, vol.23, pp.384, (Summary Text)

12. Demir Eksikliği Anemisi Hastalığında Desidustat'ın Etkililiği ve Güvenirliğinin Araştırılması: Randomize Kontrollü Çalışmaların Sistematik Derlemesi ve Meta Analizi

TANRIVERDİ L. H., SARICI A.
13th International Medicine and Heath Sciences Researches Congress, Turkey, 26 - 27 August 2023, pp.349-350, (Summary Text)

13. A Case Report of Liver Involvement in Multiple Myeloma

BİÇİM S., BERBER İ., KUKU İ., KAYA E., ERKURT M. A., KAYA A., et al.
WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, 14 - 17 September 2022, (Full Text)

14. Otolog Kök Hücre Nakli Öncesi Ferritin Düzeyi Nakil Sonuçlarında Etkili Mi? Tek Merkez Deneyimi

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
5. Hematolojik Nadir Hastalıklar Kongresi, Cyprus (Kktc), 24 - 27 March 2022, (Summary Text)

15. HA330 Hemoperfüzyon Adsorbsiyon yönteminin sepsiste inflamatuar belirteçler ve end organ hasar düzeyleri üzerine etkileri: Retrospektif tek merkezli çalışma

ERKURT M. A., SARICI A., ÖZER A. B., KUKU İ., KAYA E., BİÇİM S., et al.
5. Hematolojik Nadir Hastalıklar Kongresi, Cyprus (Kktc), 24 - 27 March 2022, (Summary Text)

16. MİYELOFİBROZİSE SEKONDER MULTİPLE MİYELOM: NADİR GÖRÜLEN BİR OLGU SUNUMU

BİÇİM S., SARICI A., ŞAHİN A. Ş., BERBER İ., KUKU İ., KAYA E., et al.
4. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, DİJİTAL KONGRE, Turkey, 30 September - 03 October 2021, pp.41-44, (Summary Text)

17. AKUT LENFOBLASTİK LÖSEMİLİ HASTADA GÖRÜLEN CİLT TUTULUMU

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Turkey, 25 - 27 December 2020, pp.150, (Summary Text)

18. OTOLOG HEMATOPOETİK KÖK HÜCRE NAKLİ YAPILAN MİKOZİS FUNGOİDES VAKASI

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Turkey, 25 - 27 December 2020, pp.153, (Summary Text)

19. MULTİPL MYELOM HASTASINDA GÖRÜLEN COVİD-19 HASTALIĞI

SARICI A., BİLGİÇ Y., AKBAŞ S., BİÇİM S., BERBER İ., ERKURT M. A., et al.
3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Turkey, 25 - 27 December 2020, pp.148-149, (Summary Text)

20. Covid-19 Hastalarında Hastalık Şiddetiyle İlişkili Klinik Özellikler ve Laboratuvar Değerleri : Tek Merkez Deneyimi

YILDIRIM A., KIRICI BERBER N., ULUTAŞ Ö., SARICI A., ÇAĞAŞAR Ö., GÖZÜKARA BAĞ H. G., et al.
II. Hematoloji Eğitim ve Araştırma Kongresi, Turkey, 20 - 22 November 2020, (Summary Text)

21. Covid-19 Hastalarının Basit Periferik Yayma Bulgularının, Hastalığın Ciddiyeti ve Hastanede Kalış Süresi Üzerindeki Yararları

KIRICI BERBER N., BERBER İ., ÇAĞAŞAR Ö., SARICI A., AYDOĞDU İ., ULUTAŞ Ö., et al.
II. Hematoloji Eğitim ve Araştırma Kongresi, Turkey, 20 - 22 November 2020, (Summary Text)

22. GRAFT VERSUS HOST HASTALIĞINDA İBRUTİNİBKULLANIMI: TEK MERKEZ DENEYİMİ

ÖZKAN S. G., KAYA E., ERKURT M. A., SARICI A., BERBER İ., KUKU İ.
45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 30 October - 02 November 2019, (Full Text)

23. Meme Kanseri Tedavisi Sonrası Gelişen Akut Myeloid Lösemi Olgusu

SARICI A., Yiğit O. S., BAHÇECİOĞLU Ö. F., GÖK S., ERKURT M. A., KAYA E., et al.
VI.ULUSLARARASI KATILIMLI DENEYSEL HEMATOLOJİ KONGRESİ, Gaziantep, Turkey, 19 - 21 April 2019, pp.1-2, (Summary Text)

24. TEKRARLAYAN SEREBROVASKÜLER OLAY ATAKLARI VE DALAK ENFARKTI İLE GELEN BİR PANMYELOZİS OLGUSU

SARICI A., ŞAHİN F. T., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.69, (Summary Text)

25. AKUT MYELOİD LÖSEMİ TANILI HASTADA SİTARABİN KEMOTERAPİSİ ESNASINDA TROMBOSİTOZ GELİŞİMİ

SLOCUM A., SARICI A., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.49, (Summary Text)

26. ERİŞKİNDE NADİR GÖRÜLEN KONGENİTAL DİSERİTROPOİETİK SENDROM- II OLGUSU

SARICI A., ŞAHİN F. T., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.68, (Summary Text)

27. HEMATOPOETİK KÖK HÜCRE NAKLİ’NDE DONÖR OLAN VAKADA HODGKİN LENFOMA GELİŞİMİ

SARICI A., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.66, (Summary Text)

28. BETA TALASEMİ MAJOR TANILI HASTADA ALLOGENEİK KÖK HÜCRE NAKLİ SONRASI ENGRAFTMAN GELİŞMEMESİ

SARICI A., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.65, (Summary Text)

29. TURGUT ÖZAL TIP MERKEZİ’NDE TAKİP EDİLEN KRONİK MYELOİD LÖSEMİ TANILI HASTALARIN TEDAVİ YANITLARI

SARI M., SARICI A., KAYA E., ERKURT M. A., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.63, (Summary Text)

30. İDİOPATİK TROMBOSİTOPENİK PURPURA TANILI HASTADA TROMBOSİTOPENİ NEDENİ OLARAK TESPİT EDİLEN AKSESUAR DALAK

SARICI A., KUKU İ., ERKURT M. A., KAYA E.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.51, (Summary Text)
Metrics

Publication

114

Publication (WoS)

39

Publication (Scopus)

40

Citation (WoS)

108

H-Index (WoS)

5

Citation (Scopus)

122

H-Index (Scopus)

5

Citation (Scholar)

242

H-Index (Scholar)

7

Project

2

Open Access

9
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS